We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.95B
AUM Growth
+$407M
Cap. Flow
+$737M
Cap. Flow %
9.28%
Top 10 Hldgs %
63.45%
Holding
409
New
72
Increased
88
Reduced
65
Closed
155

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$49.7M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$49.3M
3
IMCR icon
Immunocore
IMCR
+$41.4M
4
EXAS
Exact Sciences
EXAS
+$36.8M
5
IMVT icon
Immunovant
IMVT
+$35.1M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$92.8M
2
KO icon
Coca-Cola
KO
+$36M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$31.9M
4
POST icon
Post Holdings
POST
+$26.8M
5
NOMD icon
Nomad Foods
NOMD
+$26.4M

Sector Composition

Rank Sector Weight
1 Healthcare 33.06%
2 Consumer Staples 5.21%
3 Consumer Discretionary 4.94%
4 Technology 3.72%
5 Materials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNRG icon
276
Brenmiller Energy
BNRG
$1.06M
– –
-1,046
Closed -$366K
BOOT icon
277
Boot Barn
BOOT
$4.89B
– –
-4,211
Closed -$401K
BRBR icon
278
BellRing Brands
BRBR
$1.45B
– –
-9,439
Closed -$557K
CAG icon
279
Conagra Brands
CAG
$7.14B
– –
-7,382
Closed -$219K
CHE icon
280
Chemed
CHE
$7.06B
– –
-442
Closed -$284K
CL icon
281
Colgate-Palmolive
CL
$74.4B
– –
-4,259
Closed -$384K
CLBT icon
282
Cellebrite
CLBT
$3.89B
– –
-16,618
Closed -$184K
CNSP icon
283
CNS Pharmaceuticals
CNSP
$7.75M
– –
-16
Closed -$171K
ZSQR
284
Z Squared Inc
ZSQR
$220M
– –
-151,513
Closed -$901K
COIN icon
285
Coinbase
COIN
$39.9B
– –
-851
Closed -$226K
COLM icon
286
Columbia Sportswear
COLM
$2.94B
– –
-11,800
Closed -$958K
CROX icon
287
Crocs
CROX
$6.52B
– –
-22,428
Closed -$3.23M
CVCO icon
288
Cavco Industries
CVCO
$4.5B
– –
-543
Closed -$217K
CVKD icon
289
Cadrenal Therapeutics
CVKD
$6.51M
– –
-89,972
Closed -$823K
DDS icon
290
Dillards
DDS
$9.66B
– –
-1,804
Closed -$851K
DLTR icon
291
Dollar Tree
DLTR
$24.7B
– –
-4,893
Closed -$652K
DOO
292
Bombardier Recreational Products
DOO
$4.86B
– –
-3,127
Closed -$210K
DRMAW icon
293
Dermata Therapeutics Warrant
DRMAW
$16.3K
– –
-20,312
Closed -$193
DUK icon
294
Duke Energy
DUK
$96.2B
– –
-2,846
Closed -$275K
DUOL icon
295
Duolingo
DUOL
$6.28B
– –
-3,946
Closed -$870K
EDBLW
296
Edible Garden AG Warrant
EDBLW
$72.3K
– –
-26,666
Closed -$408
EFX icon
297
Equifax
EFX
$20.5B
– –
-933
Closed -$250K
EG icon
298
Everest Group
EG
$14.3B
– –
-505
Closed -$201K
ERAS icon
299
Erasca
ERAS
$6.45B
– –
-6,172,000
Closed -$12.7M
ERIE icon
300
Erie Indemnity
ERIE
$12.9B
– –
-909
Closed -$365K
10 11
12
13 14

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Armistice Capital held 409 positions worth $7.95B, up 5.4% from $7.54B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Armistice Capital deployed $737M of net new capital in Q2 2024, opening 72 new positions and adding to 88 existing holdings. Its largest new stake was Simply Good Foods: 957,163 shares worth $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Coca-Cola, an estimated $36M trimmed.

  • Armistice Capital's largest Q2 2024 buy was Simply Good Foods: 957,163 shares worth $34.6M.
  • Armistice Capital added most to Alkermes in Q2 2024, an estimated $49.7M increase.
  • Armistice Capital's biggest Q2 2024 reduction was Coca-Cola, cutting an estimated $36M.
  • Armistice Capital fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2024, selling an estimated $92.8M.
  • Armistice Capital's ten largest holdings make up 63% of its $7.95B portfolio in Q2 2024.
  • Armistice Capital opened 72 new positions and closed 155 in Q2 2024.
  • Armistice Capital's portfolio value rose 5.4% quarter-over-quarter to $7.95B.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.